Article
Hsa-circ-0001860 promotes Smad7 to enhance MPA resistance in endometrial cancer via miR-520h
2020-06-30
Abstract excerpt
<title>Abstract</title> <p>Background Medroxyprogesterone acetate (MPA) is one of the most commonly prescribed progestin for the treatment of endometrial cancer (EC). Despite initial benefits, many patients ultimately develop progesterone resistance. Circular RNA (circRNA) is a kind of noncoding RNA, contributing greatly to the development of human tumor. However, the role of circular RNA in MPA resistance is unk...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bf3849ce-bbce-5850-b71a-da65d139009b
- DOI
- 10.21203/rs.3.rs-38066/v1
